Dr. Reddys Laboratories informs about press release

06 Jun 2017 Evaluate

Dr. Reddys Laboratories has informed about a press release titled ‘Dr. Reddys Laboratories announces the launch of Bivalirudin for Injection in the US Market’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1218.40 9.95 (0.82%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×